Insider Stock‑Option Exercise Signals Confidence in SAB Biotherapeutics’ Near‑Term Outlook
Insider option purchases at SAB Biotherapeutics signal growing confidence, highlighting potential upside as the company advances its clinical pipeline and seeks new partnerships.
3 minutes to read